NXGL
NXGL
NASDAQ · Health Care

Nexgel Inc

$0.60
+0.01 (+1.25%)
As of May 16, 2:28 AM ET ·
Financial Highlights (FY 2026)
Revenue
15.00M
Net Income
-3,941,855
Gross Margin
39.5%
Profit Margin
-26.3%
Rev Growth
+77.3%
D/E Ratio
0.20
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 39.5% 39.5% 62.3% 62.3%
Operating Margin -27.9% -25.1% 15.0% 15.7%
Profit Margin -26.3% -25.0% 11.4% 15.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 15.00M 8.46M 5.33M 4.69M
Gross Profit 5.92M 3.34M 3.32M 2.92M
Operating Income -4,190,854 -2,127,577 798.7K 735.9K
Net Income -3,941,855 -2,001,167 604.4K 705.4K
Gross Margin 39.5% 39.5% 62.3% 62.3%
Operating Margin -27.9% -25.1% 15.0% 15.7%
Profit Margin -26.3% -25.0% 11.4% 15.0%
Rev Growth +77.3% +77.3% +6.5% +7.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 518.0K 518.0K 6.23M 5.69M
Total Equity 2.58M 2.58M 8.36M 7.17M
D/E Ratio 0.20 0.20 0.75 0.79
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -2,784,064 -1,491,911 1.03M 893.3K
Free Cash Flow 660.3K 478.5K